EVerMed (Drug Discovery) Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $3.25M

  • Investors
  • 4

EVerMed (Drug Discovery) General Information

Description

Operator of a biotechnology company intended to realize everlasting medical treatment through the therapeutic use of extracellular vesicles. The company focuses on the use of EVs, a natural homeostatic mechanism in the human body, and tries to create new treatments that address the root causes of diseases, enabling medical professionals to provide treatment for intractable respiratory diseases using extracellular vesicles.

Contact Information

Website
www.evermed.jp
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3-25-8 Nishishinbashi
  • Minato-ku
  • Tokyo
  • Japan
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 3-25-8 Nishishinbashi
  • Minato-ku
  • Tokyo
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EVerMed (Drug Discovery) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 28-Jan-2025 $3.25M Completed Startup
To view EVerMed (Drug Discovery)’s complete valuation and funding history, request access »

EVerMed (Drug Discovery) Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Nissay Capital Venture Capital Minority
San-Ai Corporation Corporation Minority
Summit Pharmaceuticals International Corporation Minority
Waseda University Ventures Venture Capital Minority
To view EVerMed (Drug Discovery)’s complete investors history, request access »

EVerMed (Drug Discovery) FAQs

  • When was EVerMed (Drug Discovery) founded?

    EVerMed (Drug Discovery) was founded in 2024.

  • Where is EVerMed (Drug Discovery) headquartered?

    EVerMed (Drug Discovery) is headquartered in Tokyo, Japan.

  • What industry is EVerMed (Drug Discovery) in?

    EVerMed (Drug Discovery)’s primary industry is Drug Discovery.

  • Is EVerMed (Drug Discovery) a private or public company?

    EVerMed (Drug Discovery) is a Private company.

  • What is EVerMed (Drug Discovery)’s current revenue?

    The current revenue for EVerMed (Drug Discovery) is .

  • How much funding has EVerMed (Drug Discovery) raised over time?

    EVerMed (Drug Discovery) has raised $3.25M.

  • Who are EVerMed (Drug Discovery)’s investors?

    Nissay Capital, San-Ai Corporation, Summit Pharmaceuticals International, and Waseda University Ventures have invested in EVerMed (Drug Discovery).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process